Association of RAGE gene polymorphisms with type 2 diabetes mellitus, diabetic retinopathy and diabetic nephropathy

Gene

Volumn 500, Issue 1, 2012, Pages 1-9

  Kang, Peipei ^a   Tian, Changwei ^a   Jia, Chongqi ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Diabetic nephropathy; Diabetic retinopathy; Meta analysis; Polymorphism; RAGE; Type 2 diabetes mellitus

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CYSTEINE; GLYCINE; SERINE; THREONINE;

ALLELE; AMINO ACID SUBSTITUTION; CASE CONTROL STUDY; CLINICAL ASSESSMENT; CLINICAL RESEARCH; COHORT ANALYSIS; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; ETHNICITY; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GROUPS BY AGE; HUMAN; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROMOTER REGION; PUBLICATION; RACE DIFFERENCE; REVIEW; RISK FACTOR; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

AMINO ACID SUBSTITUTION; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; HUMANS; POLYMORPHISM, GENETIC; RECEPTORS, IMMUNOLOGIC;

EID: 84860351065     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.03.056     Document Type: Review

References (49)

1. Balasubbu S., et al. Association analysis of nine candidate gene polymorphisms in Indian patients with type 2 diabetic retinopathy. BMC Med. Genet. 2010, 11:158.
2. Bucciarelli L.G., et al. RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease. Cell. Mol. Life Sci. 2002, 59:1117-1128.
3. dos Santos K.G., Canani L.H., Gross J.L., Tschiedel B., Pires Souto K.E., Roisenberg I. The -374A allele of the receptor for advanced glycation end products gene is associated with a decreased risk of ischemic heart disease in African-Brazilians with type 2 diabetes. Mol. Genet. Metab. 2005, 85:149-156.
4. Gao J.X., Xu D.L., Shao Y.H., Lao W.Y., Lin S., Zhang B. Association of Gly82Ser polymorphism of receptor for advanced glycation end products gene in a type 2 diabetic Chinese population. Nan Fang Yi Ke Da Xue Xue Bao 2007, 27:219-222.
5. Globocnik Petrovic M., Steblovnik K., Peterlin B., Petrovic D. The - 429 T/C and - 374 T/A gene polymorphisms of the receptor of advanced glycation end products gene are not risk factors for diabetic retinopathy in Caucasians with type 2 diabetes. Klin. Monbl. Augenheilkd. 2003, 220:873-876.
6. Goulart A.C., Germer S., Rexrode K.M., Martin M., Zee R.Y. Polymorphisms in advanced glycosylation end product-specific receptor (AGER) gene, insulin resistance, and type 2 diabetes mellitus. Clin. Chim. Acta 2008, 398:95-98.
7. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 2002, 21:1539-1558.
8. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
9. Hudson B.I., Stickland M.H., Grant P.J. Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups. Diabetes 1998, 47:1155-1157.
10. Hudson B.I., Stickland M.H., Futers T.S., Grant P.J. Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 2001, 50:1505-1511.
11. Huttunen H.J., Fages C., Rauvala H. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J. Biol. Chem. 1999, 274:19919-19924.
12. Ioannidis J.P. Commentary: grading the credibility of molecular evidence for complex diseases. Int. J. Epidemiol. 2006, 35:572-578. (discussion 593-6).
13. Kankova K., Vasku A., Hajek D., Zahejsky J., Vasku V. Association of G82S polymorphism in the RAGE gene with skin complications in type 2 diabetes. Diabetes Care 1999, 22:1745.
14. Kankova K., et al. Polymorphisms 1704G/T and 2184A/G in the RAGE gene are associated with antioxidant status. Metabolism 2001, 50:1152-1160.
15. Kankova K., et al. Polymorphisms in the RAGE gene influence susceptibility to diabetes-associated microvascular dermatoses in NIDDM. J. Diabetes Complications 2001, 15:185-192.
16. Kankova K., Beranek M., Hajek D., Vlkova E. Polymorphisms 1704G/T, 2184A/G, and 2245G/A in the rage gene are not associated with diabetic retinopathy in NIDDM: pilot study. Retina 2002, 22:119-121.
17. Kankova K., Stejskalova A., Hertlova M., Znojil V. Haplotype analysis of the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus. Nephrol. Dial. Transplant. 2005, 20:1093-1102.
18. Kankova K., et al. Genetic risk factors for diabetic nephropathy on chromosomes 6p and 7q identified by the set-association approach. Diabetologia 2007, 50:990-999.
19. Khoury M.J., Little J., Gwinn M., Ioannidis J.P. On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies. Int. J. Epidemiol. 2007, 36:439-445.
20. Kiritoshi S., et al. Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. Diabetes 2003, 52:2570-2577.
21. Kumaramanickavel G., Ramprasad V.L., Sripriya S., Upadyay N.K., Paul P.G., Sharma T. Association of Gly82Ser polymorphism in the RAGE gene with diabetic retinopathy in type II diabetic Asian Indian patients. J. Diabetes Complications 2002, 16:391-394.
22. Lander H.M., Tauras J.M., Ogiste J.S., Hori O., Moss R.A., Schmidt A.M. Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J. Biol. Chem. 1997, 272:17810-17814.
23. Liu L.M., Xiang K.S. A study for rage gly82ser polymorlhism in chinese type 2 diabetic microangiopathy. Chin. J. Diab. 2000, 8:135-138.
24. Lu L., et al. Increased glycated albumin and decreased esRAGE concentrations are associated with in-stent restenosis in Chinese diabetic patients. Clin. Chim. Acta 2008, 396:33-37.
25. Lu W., Feng B. The -374A allele of the RAGE gene as a potential protective factor for vascular complications in type 2 diabetes: a meta-analysis. Tohoku J. Exp. Med. 2010, 220:291-297.
26. Matsunaga-Irie S., et al. Relation between development of nephropathy and the p22phox C242T and receptor for advanced glycation end product G1704T gene polymorphisms in type 2 diabetic patients. Diabetes Care 2004, 27:303-307.
27. Munafo M.R., Flint J. Meta-analysis of genetic association studies. Trends Genet. 2004, 20:439-444.
28. Neeper M., et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 1992, 267:14998-15004.
29. Peng W.H., et al. RAGE gene polymorphisms are associated with circulating levels of endogenous secretory RAGE but not with coronary artery disease in Chinese patients with type 2 diabetes mellitus. Arch. Med. Res. 2009, 40:393-398.
30. Peters J.L., Sutton A.J., Jones D.R., Abrams K.R., Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA 2006, 295:676-680.
31. Prasad P., et al. Association analysis of ADPRT1, AKR1B1, RAGE, GFPT2 and PAI-1 gene polymorphisms with chronic renal insufficiency among Asian Indians with type-2 diabetes. BMC Med. Genet. 2010, 11:52.
32. Ramprasad S., Radha V., Mathias R.A., Majumder P.P., Rao M.R., Rema M. Rage gene promoter polymorphisms and diabetic retinopathy in a clinic-based population from South India. Eye (Lond.) 2007, 21:395-401.
33. Ren T., Xiang K.S., Liu L.M. An association study of diabetic neuropathy with polymorphisms of eNOS, PON1, RAGE and ALR2 Genes. Shanghai Med. J. 2003, 26:24-27.
34. Rudofsky G., et al. A 63bp deletion in the promoter of rage correlates with a decreased risk for nephropathy in patients with type 2 diabetes. Exp. Clin. Endocrinol. Diabetes 2004, 112:135-141.
35. Schmidt A.M., Hori O., Brett J., Yan S.D., Wautier J.L., Stern D. Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler. Thromb. 1994, 14:1521-1528.
36. Sugaya K., et al. Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3. Genomics 1994, 23:408-419.
37. Tobias A. Assessing the influence of a single study in the meta-analysis estimate. Stata Tech. Bull. 1999, 47.
38. Uthra S., et al. Diabetic retinopathy: Validation study of ALR2, RAGE, iNOS and TNFB gene variants in a south Indian cohort. Ophthalmic Genet. 2010, 31:244-251.
39. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39:44-84.
40. Wautier M.P., Chappey O., Corda S., Stern D.M., Schmidt A.M., Wautier J.L. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am. J. Physiol. Endocrinol. Metab. 2001, 280:E685-E694.
41. Xu J.X., et al. 429T/C polymorphism of RAGE gene promoter is associated with type 2 diabetic nephropathy. Chin. J. Endocrinol. Metab. 2004, 20:534-535.
42. Xu J.X., Yang M.G., Liu S.Q. (RAGE) Gene and Type 2 Diabetes Melltus with Nephropathy or Retinopathy. [D] 2002.
43. Yamagishi S.I., Maeda S., Matsui T., Ueda S., Fukami K., Okuda S. Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes. Biochim. Biophys. Acta 2011, 1820:663-671.
44. Yang T., Chen J.W., Zhou H.W., Duan Y. A Study for RAGE Gene Polymorphism in Chinese Type 2 Diabetic Nephropathy. Acad. J. Jiangsu Univ. (Med.) 2003, 13:473-475.
45. Yang S.T., Liu H., Wang Y.M., Song D.P. The relationship study of polymorphism of GI704T of RAGE gene with diabetic nephropathy. Chin. J. Diab. 2008, 16:21-22.
46. Yoshioka K., et al. Association study of G1704T and G82S polymorphisms of RAGE gene for microalbuminuria in Japanese type 2 diabetic patients. Metabolism 2005, 54:488-491.
47. Yoshioka K., et al. Relation between polymorphisms G1704T and G82S of rage gene and diabetic retinopathy in Japanese type 2 diabetic patients. Intern. Med. 2005, 44:417-421.
48. Zhang H.M., Chen L.L. The Study of the Association between TLR4,RAGE Gene Polymorphisms and Diabetes, and the Association between TLR4 Expression in White Adipose Tissue and Obesity in Wuhan Chineses population. [D] 2008.
49. Zhang H.M., et al. Association of 1704G/T and G82S polymorphisms in the receptor for advanced glycation end products gene with diabetic retinopathy in Chinese population. J. Endocrinol. Invest. 2009, 32:258-262.